The price of estrogen replacement therapies used to treat menopause symptoms doubled between 2014 and 2018, according to an analysis from GoodRx. 1. About half of the 55 million American women over ...
PRINCETON, N.J., Dec. 2 Novo Nordisk said today that the U.S. Food and Drug Administration (FDA) has approved a 10 mcg dose formulation of Vagifem® (estradiol vaginal tablets) for the treatment of ...
Study results showed substantially lower systemic estradiol exposure of TX 12-004-HR when compared to Vagifem. In conjunction with the previously reported efficacy of TX 12-004-HR, this PK data ...
Please provide your email address to receive an email when new articles are posted on . Menopausal women with moderate to severe vulvovaginal symptoms assigned vaginal estradiol tablets plus a placebo ...
Vaginal estradiol was no better than gel or placebo at alleviating menopause-related vulvovaginal symptoms, researchers reported. According to the randomized clinical trial comparing low-dose vaginal ...
The newest dosing for estradiol (Vagifem) is 10 μg, and the 25 μg is being phased out – the higher dose will only be available until supplies are depleted (“Tissue changes associated with vaginal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results